JEREMY MORRIS: Open Payments
NPI 1922629591 · NICEVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,689 in 87 payments from 27 companies in 2025. Trend: 2023 $2,063 · 2024 $1,961 · 2025 $1,689
Food & beverage: $1,689
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $254 |
| Novo Nordisk Inc | 10 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $162 |
| ABBVIE INC. | 10 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $114 |
| GlaxoSmithKline, LLC. | 6 | $110 |
| Amgen Inc. | 4 | $74 |
| Lilly USA, LLC | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
Products named: AIRSUPRA, Ozempic, Kerendia, XIFAXAN, TRELEGY ELLIPTA, VRAYLAR, REXULTI, FARXIGA.
Industry payments across FL — which companies pay providers there.
